Home > Press Releases

Amedisys to Present at Multiple Healthcare Conferences in May

BATON ROUGE, La., April 29, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Chris Gerard, President and Chief Executive Officer, and Scott Ginn, Executive Vice President and Chief Financial Officer, will present and conduct investor one on ones at the Bank of America Securities 2022 Healthcare Conference on Tuesday, May 10, at 5:40 p.m. ET, the 2022 RBC Capital Markets Global Healthcare Conference on Tuesday, May 17, and the UBS Global Healthcare Conference on Monday, May 23, at 9:15 a.m. ET.

To access a live webcast of the Amedisys presentations, please log on through our website at https://investors.amedisys.com.

About Amedisys:

Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice, personal care and high-acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; inpatient hospital, palliative, and skilled nursing facility (“SNF”) care in their homes; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 3,000 hospitals and 90,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 21,000 employees, in 548 care centers in 38 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 445,000 patients in need every year, performing more than 11.5 million visits annually. For more information about the Company, please visit: www.amedisys.com.

Contact:                        
Nick Muscato
Amedisys, Inc.
Investor Relations
615.928.5452
[email protected]
 Kendra Kimmons
Amedisys, Inc.
Media Relations
225.299.3720
[email protected]